Red White & Bloom Brands Inc. is a cannabis company focused on cultivation and retail in key U.S. markets. While it boasts a decent gross margin of 33.7% and a solid current ratio of 1.74, the company faces significant concerns with a net margin of -101.3% and negative return on assets at -6.0%. The low market cap of $9.41M and stagnant share price suggest valuation challenges, despite its operational potential. Overall, while there are strengths in liquidity and gross profitability, the financial health raises red flags.
Loading financial metrics...
Company has $4.4M in cash but burned $2.8M last quarter. At this burn rate, only 1.6 quarters of runway remain without additional financing.
Revenue fell 22.5% year-over-year from $85.5M to $66.3M. The decline has persisted for multiple quarters.
Company posted a loss of $-40.7M over the last year, representing 61.5% of revenue.
Debt of $407.6M is 92.1x the company's cash position of $4.4M.
Gross profit margin decreased from 30.4% to 23.8% compared to last year.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2025-Q3 (September 30, 2025)